ConCallIQ
Go Pro
BAJAJFINSV Diversified 24 Jul 2024

Bajajfinsv Ltd — Q1 FY25

Bajaj Finserv reported a mixed Q1 FY25.

neutral medium
Revenue ₹31,480 Cr +35%
EBITDA
PAT ₹4,209 Cr +10%
EBITDA Margin 38%
Duration
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Bajaj Finserv reported a mixed Q1 FY25. Consolidated PAT grew 10% YoY to INR 2,138 crore, but excluding one-offs, growth was 8%. Revenue rose 35% to INR 31,480 crore. BAGIC posted strong GWP growth of 24% to INR 4,761 crore, though combined ratio worsened to 103.7% due to large commercial claims. BALIC's individual rated new business grew 26%, but PAT fell 37% due to new business strain. Bajaj Finance resumed eCom and Insta EMI card issuance post-RBI embargo. Emerging businesses' losses widened to INR 119 crore. Management highlighted margin pressure from regulatory changes and elevated loan losses, but expects improvement in H2. Key risk: elevated credit costs and collection efficiency in BFL's rural portfolio.

Key Numbers

Gross Written Premium (BAGIC) INR 4,761 crore
+24% YoY

BAGIC grew at double the industry pace, gaining market share to 6.5%.

Individual Rated New Business (BALIC) INR 1.55 lakh policies
+26% YoY

BALIC's IRNB growth outpaced industry and private sector, with market share rising to 9%.

Combined Ratio (BAGIC) 103.7%
+300bps YoY

Deterioration driven by large commercial claims; underwriting profit still positive on NEP basis.

AUM (Bajaj Housing Finance) INR 97,000 crore
+31% YoY

BHFL AUM nearing INR 1 lakh crore; DRHP filed for potential IPO.

What Changed vs Last Quarter

Comparing Q1 FY25 vs Q4 FY24
4 new guidance3 dropped4 new risk4 risk resolved
NEW
BAGIC expects combined ratio to normalize in subsequent quarters

Management indicated that large commercial claims in Q1 are one-offs and not expected to recur, with combined ratio likely improving.

NEW
BALIC margins may see a pause in expansion this year due to surrender regulations

New surrender value norms could temporarily impact margin expansion, but medium-term expansion expected through product filings and cost optimization.

NEW
BFL expects collection efficiency to improve in H2

Steps taken to strengthen collections and slow rural B2C business should yield results in the second half of FY25.

NEW
Bajaj Finserv Health to provide long-term plan in 6-9 months

Post-Vidal acquisition, management will outline a complete long-range plan including breakeven visibility within 6-9 months.

DROPPED
BAGIC to maintain above-market growth with balanced profitability

Management expects continued market share gains driven by distribution expansion and prudent underwriting, but no specific growth target given.

DROPPED
BALIC to grow faster than industry with improving margins

Directionally, NBV margins expected to improve due to scale and cost efficiencies, though no specific numbers provided.

DROPPED
Bajaj Finserv Health to integrate Vidal acquisition in Q1 FY25

Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.

NEW RISK
Elevated loan losses and collection efficiency in BFL

BFL's loan losses and provisions were elevated in Q1 due to muted collection efficiencies and increase in stage 2 assets by INR 864 crore.

NEW RISK
Impact of new surrender regulations on BALIC margins

New IRDA surrender value norms may temporarily slow margin expansion; management was evasive on quantifying the impact.

NEW RISK
Large commercial claims in BAGIC may recur

Though termed one-offs, large property and liability claims caused combined ratio deterioration; similar claims could arise in future.

NEW RISK
Vidal acquisition may lead to customer attrition

Insurance partners of Vidal may withdraw business due to conflict of interest with Bajaj Finserv's insurance arms.

RISK GONE
Motor TP pricing uncertainty

No price hike in motor third-party for years; frequency of accidents rising, and regulatory approval for hike is uncertain, especially in an election year.

RISK GONE
Regulatory risk on surrender charges for life insurance

Regulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.

RISK GONE
Dependence on tender-driven government health and crop business

Growth in government health and crop is tender-based and pricing-dependent; management may lose share if pricing becomes unfavorable.

RISK GONE
Persistency pressure in life insurance from older cohorts

37th month persistency dropped due to a specific partner bucket; 49th month may also be impacted, though overall persistency improving.

🤫 Topics management stopped discussing

Bajaj Finserv Health to integrate Vidal acquisition in Q1 FY25

Mentioned in Q3 FY24, Q4 FY24

Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.

BALIC NBV growth expected to continue with product mix improvement

Mentioned in Q1 FY24, Q2 FY24

Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.

Competition in crop insurance and government health

Mentioned in Q1 FY24, Q2 FY24

Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.

Dependence on tender-driven government health and crop business

Mentioned in Q2 FY24, Q4 FY24

Growth in government health and crop is tender-based and pricing-dependent; management may lose share if pricing becomes unfavorable.

Regulatory risk on surrender charges for life insurance

Mentioned in Q3 FY24, Q4 FY24

Regulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.

Management Guidance

G

BAGIC expects combined ratio to normalize in subsequent quarters

Management indicated that large commercial claims in Q1 are one-offs and not expected to recur, with combined ratio likely improving.

Management guidance margins
G

BALIC margins may see a pause in expansion this year due to surrender regulations

New surrender value norms could temporarily impact margin expansion, but medium-term expansion expected through product filings and cost optimization.

Management guidance margins
G

BFL expects collection efficiency to improve in H2

Steps taken to strengthen collections and slow rural B2C business should yield results in the second half of FY25.

Management guidance growth
G

Bajaj Finserv Health to provide long-term plan in 6-9 months

Post-Vidal acquisition, management will outline a complete long-range plan including breakeven visibility within 6-9 months.

Management guidance other

Key Risks

R

Elevated loan losses and collection efficiency in BFL

BFL's loan losses and provisions were elevated in Q1 due to muted collection efficiencies and increase in stage 2 assets by INR 864 crore.

high · management_commentary
R

Impact of new surrender regulations on BALIC margins

New IRDA surrender value norms may temporarily slow margin expansion; management was evasive on quantifying the impact.

medium · analyst_question
R

Large commercial claims in BAGIC may recur

Though termed one-offs, large property and liability claims caused combined ratio deterioration; similar claims could arise in future.

medium · data_observation
R

Vidal acquisition may lead to customer attrition

Insurance partners of Vidal may withdraw business due to conflict of interest with Bajaj Finserv's insurance arms.

medium · analyst_question

Notable Quotes

We do not believe such claims are recurring in nature, but it so happened in the Q1 of the year, but hopefully they will not recur in the next remaining three quarters.
S. Sreenivasan · CFO, Bajaj Finserv
Our margins have been consistently expanding over the last 4-5 years, from 7% in FY 2019 to 15% in FY 2024. The changes in regulations in the short term may temporarily impact the margin expansion.
S. Sreenivasan · CFO, Bajaj Finserv
If you are able to add value, people will work with you. That is our experience from last four, five quarters.
Devang Mody · CEO, Bajaj Finserv Health

Frequently Asked Questions

What was Bajajfinsv's revenue in Q1 FY25?

Bajajfinsv reported revenue of ₹31,480 Cr in Q1 FY25, representing a +35% change compared to the same quarter last year.

What guidance did Bajajfinsv management give for FY26?

BAGIC expects combined ratio to normalize in subsequent quarters: Management indicated that large commercial claims in Q1 are one-offs and not expected to recur, with combined ratio likely improving. BALIC margins may see a pause in expansion this year due to surrender regulations: New surrender value norms could temporarily impact margin expansion, but medium-term expansion expected through product filings and cost optimization. BFL expects collection efficiency to improve in H2: Steps taken to strengthen collections and slow rural B2C business should yield results in the second half of FY25. Bajaj Finserv Health to provide long-term plan in 6-9 months: Post-Vidal acquisition, management will outline a complete long-range plan including breakeven visibility within 6-9 months.

What are the key risks for Bajajfinsv in FY26?

Key risks include Elevated loan losses and collection efficiency in BFL — BFL's loan losses and provisions were elevated in Q1 due to muted collection efficiencies and increase in stage 2 assets by INR 864 crore.; Impact of new surrender regulations on BALIC margins — New IRDA surrender value norms may temporarily slow margin expansion; management was evasive on quantifying the impact.; Large commercial claims in BAGIC may recur — Though termed one-offs, large property and liability claims caused combined ratio deterioration; similar claims could arise in future.; Vidal acquisition may lead to customer attrition — Insurance partners of Vidal may withdraw business due to conflict of interest with Bajaj Finserv's insurance arms..

Did Bajajfinsv meet its previous quarter's guidance?

Of 3 tracked promises, management 0 met, 0 close, 3 missed.

Where can I read the full Bajajfinsv Q1 FY25 concall transcript?

The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.